Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP607959.RApd9O3lIt8qkpOL6lrhSZhsuia1D9lOW_WqyVP0BxLsY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP607959.RApd9O3lIt8qkpOL6lrhSZhsuia1D9lOW_WqyVP0BxLsY130_assertion type Assertion NP607959.RApd9O3lIt8qkpOL6lrhSZhsuia1D9lOW_WqyVP0BxLsY130_head.
- NP607959.RApd9O3lIt8qkpOL6lrhSZhsuia1D9lOW_WqyVP0BxLsY130_assertion description "[However, when analysis was carried out according to the primary neoplasia involved, a significant association was observed between the MTHFR haplotype (single nucleotide polymorphisms 677 and 1298) and the risk of developing t-MDS/AML in the breast cancer patients group (P=0.016) and cyclophosphamide-treated hematological disease group (P=0.005).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607959.RApd9O3lIt8qkpOL6lrhSZhsuia1D9lOW_WqyVP0BxLsY130_provenance.
- NP607959.RApd9O3lIt8qkpOL6lrhSZhsuia1D9lOW_WqyVP0BxLsY130_assertion evidence source_evidence_literature NP607959.RApd9O3lIt8qkpOL6lrhSZhsuia1D9lOW_WqyVP0BxLsY130_provenance.
- NP607959.RApd9O3lIt8qkpOL6lrhSZhsuia1D9lOW_WqyVP0BxLsY130_assertion SIO_000772 17476281 NP607959.RApd9O3lIt8qkpOL6lrhSZhsuia1D9lOW_WqyVP0BxLsY130_provenance.
- NP607959.RApd9O3lIt8qkpOL6lrhSZhsuia1D9lOW_WqyVP0BxLsY130_assertion wasDerivedFrom befree-2016 NP607959.RApd9O3lIt8qkpOL6lrhSZhsuia1D9lOW_WqyVP0BxLsY130_provenance.
- NP607959.RApd9O3lIt8qkpOL6lrhSZhsuia1D9lOW_WqyVP0BxLsY130_assertion wasGeneratedBy ECO_0000203 NP607959.RApd9O3lIt8qkpOL6lrhSZhsuia1D9lOW_WqyVP0BxLsY130_provenance.